A Drivsholm
- Co-authors
- J EllegaardJanni NielsenJ. ClausenJ Pedersen-BjergaardKNUD BRØCHNER‐MORTENSENH BrinckerChristian H. GeislerK Thorling
- Topics
- Chronic Lymphocytic Leukemia Research (5 papers)Acute Lymphoblastic Leukemia research (3 papers)Lymphoma Diagnosis and Treatment (3 papers)
- Journals
- Scandinavian Journal of Clinical and Laboratory InvestigationEuropean Journal Of HaematologyLeukemia Research
- Partner nations
- Denmark
In The Last Decade
A Drivsholm
13 papers receiving 235 citations
Peers
Comparison fields: 5 of 51
- Genetics 121
- Hematology 93
- Pathology and Forensic Medicine 86
- Molecular Biology 70
- Immunology 67
Countries citing papers authored by A Drivsholm
This map shows the geographic impact of A Drivsholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Drivsholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Drivsholm more than expected).
Fields of papers citing papers by A Drivsholm
This network shows the impact of papers produced by A Drivsholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Drivsholm. The network helps show where A Drivsholm may publish in the future.
Co-authorship network of co-authors of A Drivsholm
This figure shows the co-authorship network connecting the top 25 collaborators of A Drivsholm. A scholar is included among the top collaborators of A Drivsholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Drivsholm. A Drivsholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 85 | |
| 2 | 18 | |
| 3 | Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark. | 48 |
| 4 | 14 | |
| 5 | The CLL2 study: preliminary results of flow cytometry immunophenotyping in the first 500 patients. | 1 |
| 6 | 5 | |
| 7 | Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. | 22 |
| 8 | Decreased serum cobalamin in multiple myeloma without signs of vitamin B12 deficiency. A preliminary report. | 3 |
| 9 | 3 | |
| 10 | 18 | |
| 11 | 32 | |
| 12 | 12 | |
| 13 | 8 |
About A Drivsholm
A Drivsholm is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 13 papers that have together received 269 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (121 citations), Hematology (93 citations) and Pathology and Forensic Medicine (86 citations). A Drivsholm has collaborated with scholars based in Denmark. Frequent co-authors include J Ellegaard, Janni Nielsen, J. Clausen, J Pedersen-Bjergaard, KNUD BRØCHNER‐MORTENSEN, H Brincker, Christian H. Geisler, K Thorling, Elo Andersen and O. Myhre Jensen. Their work appears in journals such as Scandinavian Journal of Clinical and Laboratory Investigation, European Journal Of Haematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.